Bharat Biotech’s Suchitra Ella says vaccines shouldn’t be a barrier to enter any nation if approved by national regulatory authorities
Vaccines should not become a barrier to enter any nation, Suchitra Ella, Joint managing director,...
Read More
Category: Regulatory Affairs
Merck asks US FDA to authorize promising anti-COVID pill
Drugmaker Merck NSE 0.23 % asked U.S. regulators Monday to authorize its pill against...
Read More
India delays COVID-19 vaccine supplies to WHO-backed COVAX: Sources
India has delayed committing supplies of vaccine to the COVAX global sharing platform, two sources...
Read More
FDA Vaccine Committee Will Review Merck’s Oral COVID-19 Pill
After getting approval from Subject Expert Committee (SEC) for Covaxin to be used for children in...
Read More
